Evidence map›Paper›PMID 37021543›Full record

ArticleHaematologica2023

Functional, biochemical, molecular and clinical characterization of antithrombin c.1157T>C (p.Ile386Thr), a recurrent Polish variant with a founder effect.

Anna Weronska, Belen De la Morena-Barrio, Sarah Goldman-Mazur, Maria Eugenia De la Morena-Barrio, José Padilla, Antonia Miñano, Pedro Garrido, Jacek Treliński, Daniel Piotr Potaczek, Anita Szczepanek and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Anna WeronskaFaculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland.
Belen De la Morena-BarrioRegional Hemodonation Center, University of Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Sarah Goldman-MazurDepartment of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany.
Maria Eugenia De la Morena-BarrioRegional Hemodonation Center, University of Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
José PadillaRegional Hemodonation Center, University of Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Antonia MiñanoRegional Hemodonation Center, University of Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Pedro GarridoRegional Hemodonation Center, University of Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Jacek TrelińskiDepartment of Hemostasis Disorders, Medical University of Lodz, Łódź, Poland.
Daniel Piotr PotaczekTranslational Inflammation Research Division and Core Facility for Single Cell Multiomics, Medical Faculty, Philipps University of Marburg, Marburg, Germany; Center for Infection and Genomics of the Lung (CIGL), Universities of Gießen and Marburg Lung Center (UGMLC), Gießen, Germany; Bioscientia MVZ Labor Mittelhessen GmbH, Gießen, Germany.
Anita SzczepanekInstitute of Archaeology and Ethnology, Polish Academy of Sciencies, Kraków, Poland; Department of Anatomy, Jagiellonian University Medical College, Kraków, Poland.
Anetta UndasInstitute of Cardiology, Jagiellonian University Medical College, Kraków, Poland; John Paul II Hospital, Kraków, Poland.
Javier CorralRegional Hemodonation Center, University of Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain. javiercorraldelacalle@gmail.com.
Ewa WypasekFaculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University, Kraków, Poland; John Paul II Hospital, Kraków, Poland. ewa.wypasek@wp.pl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntithrombinsFounder EffectAnticoagulantsAntithrombin IIIHumansMutationPolandAnticoagulantsAntithrombin IIIAntithrombins

Identifiers

PMID37021543
PMCPMC10542824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.